Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FR9VW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,426
Award facts
- Contract value 100% obligated
- $63,425.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,425.64 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used primarily to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, reflecting the pharmaceutical distributor's role in supplying specialized medical products to federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated sustained capability to fulfill federal requirements through open competition across a diverse portfolio of therapeutic domains and transaction values.
Quick answers
Who was awarded contract SPE2DB25FR9VW?
SPE2DB25FR9VW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FR9VW worth?
The government has obligated $63,426 on SPE2DB25FR9VW.
Is contract SPE2DB25FR9VW an order under another contract?
Yes. SPE2DB25FR9VW is a delivery order under SPE2DB22D2103, an indefinite delivery contract.
Was contract SPE2DB25FR9VW competed?
The extent of competition for SPE2DB25FR9VW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award